These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 30720188)

  • 1. Intestinal permeability in physiological and pathological conditions: major determinants and assessment modalities.
    Graziani C; Talocco C; De Sire R; Petito V; Lopetuso LR; Gervasoni J; Persichilli S; Franceschi F; Ojetti V; Gasbarrini A; Scaldaferri F
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):795-810. PubMed ID: 30720188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD.
    Pierantonelli I; Rychlicki C; Agostinelli L; Giordano DM; Gaggini M; Fraumene C; Saponaro C; Manghina V; Sartini L; Mingarelli E; Pinto C; Buzzigoli E; Trozzi L; Giordano A; Marzioni M; Minicis S; Uzzau S; Cinti S; Gastaldelli A; Svegliati-Baroni G
    Sci Rep; 2017 Sep; 7(1):12200. PubMed ID: 28939830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal permeability changes with bacterial translocation as key events modulating systemic host immune response to SARS-CoV-2: A working hypothesis.
    Cardinale V; Capurso G; Ianiro G; Gasbarrini A; Arcidiacono PG; Alvaro D
    Dig Liver Dis; 2020 Dec; 52(12):1383-1389. PubMed ID: 33023827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of non-steroidal anti-inflammatory drugs on intestinal permeability and nonalcoholic fatty liver disease.
    Utzeri E; Usai P
    World J Gastroenterol; 2017 Jun; 23(22):3954-3963. PubMed ID: 28652650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders.
    Chopyk DM; Grakoui A
    Gastroenterology; 2020 Sep; 159(3):849-863. PubMed ID: 32569766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of the Gut-Liver Axis in Metabolic Dysfunction-Associated Fatty Liver Disease.
    Martín-Mateos R; Albillos A
    Front Immunol; 2021; 12():660179. PubMed ID: 33936094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantation.
    Nicoletti A; Ponziani FR; Biolato M; Valenza V; Marrone G; Sganga G; Gasbarrini A; Miele L; Grieco A
    World J Gastroenterol; 2019 Sep; 25(33):4814-4834. PubMed ID: 31543676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breakdown of intestinal mucosa via accelerated apoptosis increases intestinal permeability in experimental severe acute pancreatitis.
    Yasuda T; Takeyama Y; Ueda T; Shinzeki M; Sawa H; Nakajima T; Kuroda Y
    J Surg Res; 2006 Sep; 135(1):18-26. PubMed ID: 16603187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut-liver axis signaling in portal hypertension.
    Simbrunner B; Mandorfer M; Trauner M; Reiberger T
    World J Gastroenterol; 2019 Oct; 25(39):5897-5917. PubMed ID: 31660028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal Immune Dysregulation Driven by Dysbiosis Promotes Barrier Disruption and Bacterial Translocation in Rats With Cirrhosis.
    Muñoz L; Borrero MJ; Úbeda M; Conde E; Del Campo R; Rodríguez-Serrano M; Lario M; Sánchez-Díaz AM; Pastor O; Díaz D; García-Bermejo L; Monserrat J; Álvarez-Mon M; Albillos A
    Hepatology; 2019 Sep; 70(3):925-938. PubMed ID: 30414342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protease-activated receptor signaling in intestinal permeability regulation.
    Pontarollo G; Mann A; Brandão I; Malinarich F; Schöpf M; Reinhardt C
    FEBS J; 2020 Feb; 287(4):645-658. PubMed ID: 31495063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of Fructo-Oligosaccharides on Gut Permeability and Inflammatory Responses in the Cecal Mucosa Quite Differs between Rats Fed Semi-Purified and Non-Purified Diets.
    Genda T; Kondo T; Hino S; Sugiura S; Nishimura N; Morita T
    J Nutr Sci Vitaminol (Tokyo); 2018; 64(5):357-366. PubMed ID: 30381626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. They Must Hold Tight: Junction Proteins, Microbiota And Immunity In Intestinal Mucosa.
    Castoldi A; Favero de Aguiar C; Moraes-Vieira PM; Olsen Saraiva Câmara N
    Curr Protein Pept Sci; 2015; 16(7):655-71. PubMed ID: 26122786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The gut barrier: new acquisitions and therapeutic approaches.
    Scaldaferri F; Pizzoferrato M; Gerardi V; Lopetuso L; Gasbarrini A
    J Clin Gastroenterol; 2012 Oct; 46 Suppl():S12-7. PubMed ID: 22955350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota changes and chronic hepatitis C virus infection.
    Preveden T; Scarpellini E; Milić N; Luzza F; Abenavoli L
    Expert Rev Gastroenterol Hepatol; 2017 Sep; 11(9):813-819. PubMed ID: 28621554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal permeability is increased in children with non-alcoholic fatty liver disease, and correlates with liver disease severity.
    Giorgio V; Miele L; Principessa L; Ferretti F; Villa MP; Negro V; Grieco A; Alisi A; Nobili V
    Dig Liver Dis; 2014 Jun; 46(6):556-60. PubMed ID: 24631029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In this issue: Effect of gut microbiome on mucosal immunity and enteric diseases.
    Kumar H; Bot A
    Int Rev Immunol; 2018 Mar; 37(2):77-78. PubMed ID: 29558285
    [No Abstract]   [Full Text] [Related]  

  • 18. The Intestinal Epithelium: Central Coordinator of Mucosal Immunity.
    Allaire JM; Crowley SM; Law HT; Chang SY; Ko HJ; Vallance BA
    Trends Immunol; 2018 Sep; 39(9):677-696. PubMed ID: 29716793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Manipulation of epithelial integrity and mucosal immunity by host and microbiota-derived metabolites.
    Kayama H; Takeda K
    Eur J Immunol; 2020 Jul; 50(7):921-931. PubMed ID: 32511746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of mucosal integrity by quantifying neutrophil granulocyte influx in murine models of acute intestinal injury.
    Fischer JC; Wintges A; Haas T; Poeck H
    Cell Immunol; 2017 Jun; 316():70-76. PubMed ID: 28413062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.